Publisher
Springer Nature Singapore
Reference6 articles.
1. Buck LM. Use of methylnaltrexone for refractory opioid-induced constipation in children. 2014. Available https://med.virginia.edu/pediatrics/wp-content/uploads/sites/237/2015/12/201403.pdf. Accessed 22 June 2021.
2. Hanson B, Siddique SM, Scarlett Y, Sultan S. American Gastroenterological Association Institute technical review on the medical management of opioid-induced constipation. Gastroenterology. 2019;156(1):229–53.
3. Hyman PE, Di Lorenzo C, Prestridge LL, Youssef NN, Ueno R. Lubiprostone for the treatment of functional constipation in children. J Pediatr Gastroenterol Nutr. 2014;58(3):283–91. https://doi.org/10.1097/MPG.0000000000000176. PMID: 24048162.
4. Novak C, Hogg A, Sue K, Davies D. Peripherally acting μ-opioid receptor antagonists for treatment of opioid-induced constipation in children. Paediatr Child Health. 2021;26(2):e105–9.
5. Rao VL, Micic D, Davis AM. Medical management of opioid-induced constipation. JAMA. 2019;322(22):2241–2. https://doi.org/10.1001/jama.2019.15852.